CATHERINE MAYO: Open Payments
NPI 1063147841 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$358 in 15 payments from 8 companies in 2025. Trend: 2023 $113 · 2024 $896 · 2025 $358
Food & beverage: $336Education: $22
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $106 |
| Fresenius USA Marketing, Inc. | 4 | $90 |
| Amgen Inc. | 2 | $43 |
| Mallinckrodt Hospital Products Inc. | 1 | $31 |
| AKEBIA THERAPEUTICS INC | 1 | $28 |
| OPKO Pharmaceuticals, LLC | 1 | $22 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
Products named: VELPHORO, Vanrafia, TAVNEOS, Fabhalta, ACTHAR, Vafseo, RAYALDEE, Kerendia.
Industry payments across VA — which companies pay providers there.
